ArticlePloS one2021

Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).

Natsuda Aumpan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.